THOXF (Bioporto AS) LT-Debt-to-Total-Asset: 0.04 (As of Dec. 2025)

What is Bioporto AS LT-Debt-to-Total-Asset?

Bioporto AS THOXF 66 LT-Debt-to-Total-Asset is 0.04 as of Dec. 2025. GuruFocus rates THOXF with a GF Score™ of 66/100 and a GF Value™ of $0.17. The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Bioporto AS's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.04.

Bioporto AS's long-term debt to total assets ratio declined from Dec. 2024 (0.08) to Dec. 2025 (0.04). It may suggest that Bioporto AS is progressively becoming less dependent on debt to grow their business.

Bioporto AS (OTCPK:THOXF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Bioporto AS LT-Debt-to-Total-Asset Related Terms

Bioporto AS LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Bioporto AS's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioporto AS LT-Debt-to-Total-Asset Chart

Bioporto AS Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.13

0.07

0.05

0.08

0.04

Bioporto AS Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.08	0.09	0.07	0.07	0.04

66GF Score

Bioporto AS THOXF

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bioporto AS LT-Debt-to-Total-Asset Calculation

Bioporto AS's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	0.635	/	14.609
	=	0.04

Bioporto AS's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	0.635	/	14.609
	=	0.04

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.04 mean?

Bioporto AS (THOXF) has a LT-Debt-to-Total-Asset of 0.04 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Bioporto AS and its competitors.

Is Bioporto AS's LT-Debt-to-Total-Asset too high?

Bioporto AS's current LT-Debt-to-Total-Asset is 0.04. Overall, Bioporto AS has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.

How does Bioporto AS's LT-Debt-to-Total-Asset compare to TMO and DHR?

Bioporto AS's LT-Debt-to-Total-Asset of 0.04 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Diagnostics & Research company?

A good LT-Debt-to-Total-Asset depends on the Medical Diagnostics & Research industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Bioporto AS and its competitors. Bioporto AS's current LT-Debt-to-Total-Asset is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bioporto AS stock overvalued right now?

Bioporto AS (THOXF) has a current LT-Debt-to-Total-Asset of 0.04. The stock's GF Value™ is $0.17, compared to a current price of $0.15 — trading 12.4% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.04. Bioporto AS's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Bioporto AS (THOXF), the current LT-Debt-to-Total-Asset is 0.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioporto AS (THOXF) Overvalued in 2026?

Based on GuruFocus' analysis, Bioporto AS stock appears to be undervalued. The current stock price of $0.15 is trading 12.4% below its estimated GF Value™ of $0.17.

Key valuation signals for THOXF:

LT-Debt-to-Total-Asset: 0.04
GF Value™: $0.17 vs. price of $0.15 (12.4% below fair value)
GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the THOXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioporto AS Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN MTD DGX LH GH MEDP XPAR:ERF ICLR RVTY CRL XPAR:BIM

Other Exchanges BIOPOR:Denmark

Address Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900

Website https://www.bioporto.com

Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America. Geographically, its business area is in North America, Denmark, and rest of Europe, and Asia. The products of the company involve: ProNephro AKI, The NGAL Test, Antibodies, ELISA Kits, gRad Lateral Flow, and others.

66GF Score

Get the complete analysis for THOXF

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15

Price

$0.17

GF Value

View THOXF Analysis

See LT-Debt-to-Total-Asset data for all stocks →